Surface-modified nanocarriers for nose-to-brain delivery: from bioadhesion to targeting

F Sonvico, A Clementino, F Buttini, G Colombo… - Pharmaceutics, 2018 - mdpi.com
In the field of nasal drug delivery, nose-to-brain delivery is among the most fascinating
applications, directly targeting the central nervous system, bypassing the blood brain barrier …

Chitosan-decorated nanoparticles for drug delivery

ML Del Prado-Audelo, IH Caballero-Florán… - Journal of Drug Delivery …, 2020 - Elsevier
Chitosan is a natural polymer extensively applied in the cosmetic, textile, food, and
agricultural industries. Chitosan possesses biocompatibility, biodegradability, and …

Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: In vitro and ex vivo evaluation of efficacy and safety

AT Chatzitaki, S Jesus, C Karavasili… - International journal of …, 2020 - Elsevier
Nose-to-brain delivery is an attractive route for direct drug delivery to the central nervous
system (CNS), avoiding hepatic first-pass metabolism and solving blood–brain barrier …

A reevaluation of chitosan-decorated nanoparticles to cross the blood-brain barrier

H Cortés, S Alcalá-Alcalá, IH Caballero-Florán… - Membranes, 2020 - mdpi.com
The blood-brain barrier (BBB) is a sophisticated and very selective dynamic interface
composed of endothelial cells expressing enzymes, transport systems, and receptors that …

Controlled synthesis of N, N, N-trimethyl chitosan for modulated bioadhesion and nasal membrane permeability

CV Pardeshi, VS Belgamwar - International journal of biological …, 2016 - Elsevier
In an experiment to explore the bioadhesion, biocompatibility, and membrane permeation
properties, the controlled synthesis of N, N, N-trimethyl chitosan (TMC) was carried out by …

Improved brain pharmacokinetics following intranasal administration of N,N,N-trimethyl chitosan tailored mucoadhesive NLCs

CV Pardeshi, VS Belgamwar - Materials Technology, 2020 - Taylor & Francis
Here we report the development of tristearin-based nanostructured-lipid carriers (NLCs)
which were further surface-modified with mucoadhesive N, N, N-trimethyl chitosan (TMC) to …

Modeling of chitosan modified PLGA atorvastatin-curcumin conjugate (AT-CU) nanoparticles, overcoming the barriers associated with PLGA: An approach for better …

R Dash, M Yadav, J Biswal, A Chandra, VK Goel… - International Journal of …, 2023 - Elsevier
Conjugate drugs are evolving into potent techniques in the drug development process for
enhancing the biopharmaceutical, physicochemical, and pharmacokinetic properties …

Mannosylated thiolated paromomycin-loaded PLGA nanoparticles for the oral therapy of visceral leishmaniasis

I Afzal, HS Sarwar, MF Sohail, S Varikuti, S Jahan… - …, 2019 - Taylor & Francis
Aim: The present study evaluates the efficacy of paromomycin (PM)-loaded mannosylated
thiomeric nanoparticles for the targeted delivery to pathological organs for the oral therapy of …

Novel surface modified polymer–lipid hybrid nanoparticles as intranasal carriers for ropinirole hydrochloride: in vitro, ex vivo and in vivo pharmacodynamic evaluation

CV Pardeshi, VS Belgamwar, AR Tekade… - Journal of Materials …, 2013 - Springer
Here we report fabrication and evaluation of novel surface modified polymer–lipid hybrid
nanoparticles (PLN) as robust carriers for intranasal delivery of ropinirole hydrochloride …

PLGA biodegradable nanoparticles containing perphenazine or chlorpromazine hydrochloride: effect of formulation and release

M Halayqa, U Domańska - International journal of molecular sciences, 2014 - mdpi.com
In our study, poly (dl-lactide-co-glycolide)(PLGA) nanoparticles loaded with perphenazine
(PPH) and chlorpromazine hydrochloride (CPZ-HCl) were formulated by emulsion solvent …